Share
Dr. Lukasz Kowalczyk
Provation has appointed Dr. Lukasz Kowalczyk as its new Executive Medical Director, reinforcing the company’s commitment to shaping the future of healthcare through provider-centric innovation and responsible AI adoption.
A nationally recognized gastroenterologist and health technology leader, Dr. Kowalczyk brings a unique blend of clinical experience, entrepreneurial insight, and expertise in applied artificial intelligence.
Dr. Kowalczyk joins Provation with an extensive background in clinical excellence and digital transformation. As a graduate of the Mayo Clinic AI Accelerator and an active member of the HIMSS AI Advisory Group, he is widely respected for driving scalable, ethical AI frameworks within healthcare systems.
His proprietary Clinical Enterprise Value Stack (CEVS) will play a central role in guiding Provation’s strategy to deliver measurable improvements in clinical quality, operational efficiency, and financial performance.
With hands-on experience as a practicing gastroenterologist and a history of leading successful health tech initiatives, Dr. Kowalczyk brings a deeply provider-focused approach to innovation. His leadership ensures that Provation’s solutions remain tightly aligned with real-world clinical workflows, empowering physicians, hospitals, and health systems with smarter and more intuitive technologies.
In his new role, Dr. Kowalczyk will represent Provation across major industry conferences, medical societies, and advisory boards. He will actively contribute to national and global discussions on clinical quality, interoperability, and the future of procedural care. His insights will directly influence Provation’s product strategy, aligning innovation with emerging standards, evolving customer needs, and the rapidly advancing digital health landscape.
Related posts
